ARCHIVES

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

This article is from The Cancer Letter archive.

Vol. 21 No. 23 | June 9, 1995

Download PDF Visit The Full Archive

Related Articles

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012

Clinical Trials Approved By NCI’s CTEP Listed

February 25, 2005

NCAB Members Flay NIH Proposals To Kill Cancer Program, Strip Board An NCI Of Special Authority

January 25, 1980

Antoine To Leave As RP Director, Will Join ROB

November 2, 1990

Unclear Whether Insurance Will Cover AACR Losses

April 25, 2003

NCI-Approved Clinical Trials

June 24, 2005